EP1471917 - USE OF PDE5 INHIBITORS SUCH AS SILDENAFIL IN THE TREATMENT OF POLYCYSTIC OVARY SYNDROME [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 29.09.2006 Database last updated on 15.06.2024 | Most recent event Tooltip | 29.09.2006 | Application deemed to be withdrawn | published on 02.11.2006 [2006/44] | Applicant(s) | For:GB
Pfizer Limited 261 Ramsgate Road Sandwich, Kent CT13 9NJ / GB | For:AT
BE
BG
CH
CY
CZ
DE
DK
EE
ES
FI
FR
GR
HU
IE
IT
LI
LU
MC
NL
PT
SE
SI
SK
TR
Pfizer Inc. 235 East 42nd Street New York, NY 10017 / US | [N/P] |
Former [2006/29] | For:GB
Pfizer Limited 261 Ramsgate Road Sandwich, Kent CT13 9NJ / GB | ||
For:AT
BE
BG
CH
CY
CZ
DE
DK
EE
ES
FI
FR
GR
HU
IE
IT
LI
LU
MC
NL
PT
SE
SI
SK
TR
PFIZER INC. 235 East 42nd Street New York, N.Y. 10017 / US | |||
Former [2004/45] | For:GB
Pfizer Limited 261 Ramsgate Road Sandwich, Kent CT13 9NJ / GB | ||
For:AT
BE
BG
CH
CY
CZ
DE
DK
EE
ES
FI
FR
GR
HU
IE
IT
LU
MC
NL
PT
SE
SI
SK
TR
PFIZER INC. 235 East 42nd Street New York, N.Y. 10017 / US | Inventor(s) | 01 /
GHAZZI, Mahmoud Nizar, Pfizer Global Res. & Dev. Ann Arbor Laboratories, 2800 Plymouth Road Ann Arbor, MI 48105 / US | 02 /
KOPPIKER, Nandan, Parmanand, Pfizer Global Res.&Dev Ramsgate Road Sandwich, Kent CT139NJ / GB | 03 /
WESTBROOK, Simon, Lempriere, Pfizer Global Res.&Dev Ramsgate Road Sandwich, Kent CT139NJ / GB | [2004/45] | Representative(s) | Nevant, Marc, et al Pfizer European Patent Department 23-25, avenue du Docteur Lannelongue 75668 Paris Cedex 14 / FR | [N/P] |
Former [2006/16] | Nevant, Marc, et al Pfizer European Patent Department 23-25, avenue du Docteur Lannelongue 75668 Paris Cedex 14 / FR | ||
Former [2004/45] | Motion, Keith Robert Pfizer Limited, European Pharma Patent Department, Ramsgate Road Sandwich, Kent CT13 9NJ / GB | Application number, filing date | 03702809.9 | 27.01.2003 | [2004/45] | WO2003IB00257 | Priority number, date | US20020355038P | 07.02.2002 Original published format: US 355038 P | [2004/45] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO03066061 | Date: | 14.08.2003 | Language: | EN | [2003/33] | Type: | A1 Application with search report | No.: | EP1471917 | Date: | 03.11.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.08.2003 takes the place of the publication of the European patent application. | [2004/45] | Search report(s) | International search report - published on: | EP | 14.08.2003 | Classification | IPC: | A61K31/519, A61K31/155, A61P15/00 | [2004/45] | CPC: |
A61K31/155 (EP,US);
A61K31/519 (EP,US);
A61P15/00 (EP);
A61P15/08 (EP);
A61P43/00 (EP);
C07D487/04 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, SE, SI, SK, TR [2004/45] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | Title | German: | VERWENDUNG VON PDE5 INHIBITOREN, VOR ALLEM SILDENAFIL IN DER BEHANDLUNG VON POLYZYSTISCHEN OVARIALSYNDROM | [2004/45] | English: | USE OF PDE5 INHIBITORS SUCH AS SILDENAFIL IN THE TREATMENT OF POLYCYSTIC OVARY SYNDROME | [2004/45] | French: | UTILISATION D'INHIBITEURS PDE5, TEL QUE LE SILDENAFIL, DANS LE TRAITEMENT DU SYNDROME D'OVAIRE POLYKYSTIQUE | [2004/45] | Entry into regional phase | 02.08.2004 | National basic fee paid | 02.08.2004 | Designation fee(s) paid | 02.08.2004 | Examination fee paid | Examination procedure | 10.03.2003 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 02.08.2004 | Examination requested [2004/45] | 24.10.2005 | Despatch of a communication from the examining division (Time limit: M06) | 04.05.2006 | Application deemed to be withdrawn, date of legal effect [2006/44] | 08.06.2006 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2006/44] | Fees paid | Renewal fee | 07.01.2005 | Renewal fee patent year 03 | 09.01.2006 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [PX]WO0213798 (PFIZER LTD [GB], et al) [PX] 1-13 * abstract * * page 1, line 23 - page 2, line 8 * * claims 1-61 *; | [XY]US6242474 (YAMASAKI NORITSUGU [JP], et al) [X] 1-13 * abstract * [Y] 4,10-13; | [XY] - "Viagra treatment for female infertility:", PHIND, (20000503), XP002167738 [X] 1-13 * abstract * [Y] 4,10-13 | [Y] - GLUECK C J ET AL, "Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS).", THE JOURNAL OF ADOLESCENT HEALTH: OFFICIAL PUBLICATION OF THE SOCIETY FOR ADOLESCENT MEDICINE. UNITED STATES SEP 2001, (200109), vol. 29, no. 3, ISSN 1054-139X, pages 160 - 169, XP001152926 [Y] 4,10-13 * abstract * DOI: http://dx.doi.org/10.1016/S1054-139X(01)00202-6 | [Y] - PUGEAT M ET AL, "Insulin resistance, polycystic ovary syndrome and metformin.", DRUGS. NEW ZEALAND 1999, (1999), vol. 58 Suppl 1, ISSN 0012-6667, pages 41 - 46;discussion 75 - 82, XP009012355 [Y] 4,10-13 * abstract * DOI: http://dx.doi.org/10.2165/00003495-199958001-00010 |